OverviewThe Global Weight Loss Drugs Market is valued at USD 2.88 Billion in 2024 and is projected to reach a value of USD ...

Overview of Medical Radiation Shielding MarketThe Medical Radiation Shielding Market plays a critical role in ensuring safety ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / March 4, 2026 / announced today that Bill Peters, CFO, and Dan Dischner, SVP of Corp. Communication, will be presenting at the Barclays 28th Annual Global ...

Second clinical candidate from HUTCHMED’s next-generation ATTC platform —— Leveraging synergy through simultaneous inhibition of PAM pathway and EGFR signaling — Hong Kong, Shanghai & Florham Park, NJ ...

X recently announced results from additional analyses of its blockbuster FcRn inhibitor Vyvgart in the phase III Adapt Oculus study. The study evaluated the efficacy and safety of Vyvgart administered ...

ReiThera, the Italian leading Contract Development and Manufacturing Organization (CDMO) specialized in the development and GMP manufacturing of viral vectors for gene therapies and vaccines, is ...

OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, will exhibit its latest advancements in warehouse ...

Antiverse has raised $9.3M in Series A funding to expand its AI driven antibody discovery platform and has entered a research partnership with the Cystic Fibrosis Foundation to develop potential new ...

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that ...

Forma Life Sciences, Inc. today announced its launch as an independent, operator-owned contract development and manufacturing ...

Axcend and MassTech, Inc. announced that Axcend will offer the MassTech MTE30 as part of a combined liquid ...

Emerging from stealth, RecovryAI introduces AI-powered, physician-prescribed Virtual Care Assistants for post-operative recoverySAN FRANCISCO--(BUSINESS WIRE)--RecovryAI today announced that the U.S.